Objective:

To systematically evaluate the efficacy and safety of probiotics for knee osteoarthritis (KOA) symptoms, focusing on specific outcomes such as pain, stiffness, and functional limitations, using randomized controlled trial (RCT) data.

Approach:

Key Findings:

• Probiotics showed no significant adverse event differences compared to placebo, with no serious safety issues, indicating a favorable safety profile.
• Probiotics, particularly Saccharomyces boulardii and LatiLactobacillus sakei LB-P12, may offer potential benefits for alleviating KOA symptoms.
• Evidence is weakened by small sample sizes and limited studies, highlighting the need for further research to validate these findings.

Interpretation:

The findings suggest that probiotics could be beneficial for KOA management, but the current evidence is limited and requires further investigation to establish clinical relevance.

Limitations:

• Small sample sizes in included studies may limit the generalizability of the findings.
• The limited number of studies available for analysis restricts the robustness of conclusions.
• Variability in study methodologies and outcomes complicates the interpretation of results.

Conclusion:

Further research is essential to confirm the efficacy and safety of probiotics for KOA treatment, as current evidence remains inconclusive.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.